1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D8FF150DDC624B3100258B2D002CCA17
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-building-a-foundational-global-function-for-reviewing-ime-grants-review-phases-milestones?opendocument
18
19opendocument
203.238.82.77
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Case Analogs Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Digital Technology Consortium Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Pharma and Medical Device Quality New Product Planning Medical Affairs Pharmaceutical Launch Market Research Competitive Intelligence

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Market Access Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos
Database Member Home RAS Member Home

» Products & Services » » Medical Affairs » Medical Education

Building a Foundational Global Function for Reviewing IME Grants: Review Phases and Milestones

DB Image

Download FREE Excerpt

ID: 5806

Features:

5 Info Graphics

9 Data Graphics

160+ Metrics

3 Narratives

Pages/Slides: 21

Published: 2024

Delivery Format: Online PDF Document

 

License Options:


Buy Now

 

919-403-0251
Schedule a Meeting
Request a Quote


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Building a Foundational Global Function for Reviewing IME Grants: Review Phases and Milestones”

STUDY OVERVIEW

Independent Medical Education (IME) Grants programs provide a distinctive platform for biopharma organizations to endorse high-quality, evidence-based educational initiatives benefiting healthcare professionals, patients, payers, and systems worldwide. Hence, focusing on clearly defined milestones, precise duration tracking, strategic approaches, and thorough program assessment is essential to achieve impactful educational outcomes.

Best Practices, LLC undertook benchmarking research to explore how biopharma organizations can optimize their grants review process to identify and address critical educational gaps proactively. This study specifically examines the milestones and phases utilized by biopharma organizations to manage the IME grants review process efficiently. It also delves into key aspects of the grants review program including evaluation checklists, staffing alignment, and program evaluation.

KEY TOPICS

  • IME Grants Review Process
  • Grant Evaluation Checklists
  • Grant Review Approach and Staffing Levels
  • Grants Program Measurement

KEY METRICS

  • Milestones, steps or phases used by benchmark organizations to manage the overall IME Grants process
  • Average time taken by IME grants review teams to complete each phase
  • Important aspects to include on checklists when evaluating grants
  • Scenarios for opting offline reviews vs. live meetings
  • Information shared by IME operations teams with committees as a pre-read and during the meeting
  • Benchmark organizations’ approach to reviewing each grant
  • Number of global IME staff members dedicated to grant management and total grants processed by these FTEs
  • Effective data points for assessing the performance of grants programs

SAMPLE KEY FINDINGS

  • Grant Evaluation Checklists: To determine grant fundability, Program Budget, Reach and Design are the most important aspects on checklists with 91% of organizations considering them highly important.

METHODOLOGY

Best Practices, LLC conducted a comprehensive benchmarking survey involving 13 Medical leaders from 13 companies across 22 therapeutic areas. Follow-up interviews were conducted to delve deeper into the data and approaches described. Most participants represented mid-cap biopharma organizations.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Medical Device; Biotech; Health Care; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Alexion Pharmaceuticals; Alkermes; Astellas; Baxter International; Dermavant Sciences; GRAIL; Grifols; Merck; OTSUKA; Sage Therapeutics; Sanofi; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

RELATED RESEARCH